Evaluating the Antipsychotic Profile of the Preferential PDE10A Inhibitor, Papaverine

Psychopharmacology - Germany
doi 10.1007/s00213-008-1419-x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Carbon-11 Labeled Papaverine as a PET Tracer for Imaging PDE10A: Radiosynthesis, in Vitro and in Vivo Evaluation

Nuclear Medicine and Biology
Cancer ResearchNuclear MedicineRadiologyMolecular MedicineImaging
2010English

The Meanings of the Papaverine Test

Japanese Journal of Urology
Urology
1991English

Binding Profile of SM-9018, a Novel Antipsychotic Candidate.

The Japanese Journal of Pharmacology
1990English

Nimesulide, a Cyclooxygenase-2 Preferential Inhibitor, Impairs Renal Function in the Newborn Rabbit

Pediatric Research
Child HealthPediatricsPerinatology
2004English

Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

Clinical Pharmacokinetics
Pharmacology
2013English

Dopamine, the Antipsychotic Molecule: A Perspective on Mechanisms Underlying Antipsychotic Response Variability

Neuroscience and Biobehavioral Reviews
Physiological PsychologyNeuropsychologyBehavioral NeuroscienceCognitive Neuroscience
2018English

Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum

Journal of Neuroscience
Neuroscience
2008English

The Design of Preferential Trade Agreements

WTO Working Papers
2011English

The Use of Intraarterial Papaverine in the Management of Vasospasm Complicating Arteriovenous Malformation Resection

Journal of Neurosurgery
SurgeryNeurology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy